🔎 Trials Near Me

Beranda › Depresi › Ohio

Uji klinis Depresi di Ohio

26 studi untuk Depresi mencari peserta di lokasi di Ohio.

Kota di Ohio

Teks studi resmi (Bahasa Inggris)

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Cleveland Clinic, Cleveland
  • The Ohio State University, Department of Psychiatry, Columbus
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  • Seaport Investigator Site, Independence
  • Seaport Investigator Site, North Canton
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07065240

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Insight Clinical Trials, Independence
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Columbus
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07610473

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Mason
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06911112

E-Mindfulness Approaches for Living After Breast Cancer

  • Indu and Raj Soin Medical Center, Beavercreek
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • Ohio State University Comprehensive Cancer Center, Columbus
  • dan 16 lainnya
Menerima pesertaFase 3
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06748222

Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains

  • Lindner Center of Hope, Mason
Menerima pesertaFase 1/2
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06795451

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Neuro-Behavioral Clinical Research, North Canton
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06775379

Developing Resilience and Anxiety Management Through the Arts

  • Case Western Reserve University, Cleveland
Menerima peserta
Usia 8 hingga 17 · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07033052

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

  • Cleveland Clinic - Cleveland /ID# 276309, Cleveland
  • CincyScience /ID# 226318, West Chester
Menerima pesertaFase 3
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT04777357

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Avon Lake
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06966401

A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety

  • The Ohio State University Department of Psychiatry, Columbus
Menerima pesertaFase 2
Usia 21 hingga 65 · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT06820723

Virtual Poetry Workshops to Enhance Patient Well Being and Reduce Anxiety

  • Ohio State University Wexner Medical Center, Columbus
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT07717541

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Menerima pesertaStudi observasional
18 Months – 11 Years · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT07048574

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

  • The Ohio State University, Columbus
  • Charak Center for Health and Wellness, Garfield Heights
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT03887715

Teenthrive 2: Treatments for Improving Mood in Teens

  • Nationwide Children's Hospital, Columbus
Menerima peserta
Usia 12 hingga 18 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT07475845

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

  • Ohio State University Comprehensive Cancer Center, Columbus
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT07216404

A Precision Medicine Approach to Target Engagement for Emotion Regulation

  • Ohio State University, Columbus
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT05651295

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • The Ohio State University, Columbus
  • Neuro Behavioral Clinical Research, Inc., North Canton
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT06524830

Virtual Patient Groups for Sarcoidosis Associated Fatigue

  • Cleveland Clinic, Cleveland
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Apr 2026 · NCT07073963

Positive Processes and Transition to Health - Single-Session (PATH-SS)

  • Case Western Reserve University, Cleveland
Menerima pesertaMenyebutkan pembayaran untuk peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 22 Apr 2026 · NCT06900712

Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth

  • University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience, Cincinnati
Menerima pesertaFase 3
Usia 15 hingga 24 · Semua jenis kelamin · Diperbarui 11 Mar 2026 · NCT07464886

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Menerima peserta
Usia 12 hingga 22 · Semua jenis kelamin · Diperbarui 30 Okt 2025 · NCT06232304

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Avon Lake
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT06786624

Mechanisms of Rumination Change in Adolescent Depression

  • Nationwide Children's Hospital, Columbus
  • The Ohio State University, Columbus
Menerima peserta
Usia 14 hingga 17 · Semua jenis kelamin · Diperbarui 11 Agu 2025 · NCT03859297

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

  • Clinical Research Site, Cincinnati
Menerima pesertaFase 4
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Jan 2025 · NCT06223880

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.